Skip to main content
Erschienen in: Arthritis Research & Therapy 1/2016

Open Access 01.12.2016 | Erratum

Erratum to: Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice

verfasst von: Daniela Impellizzeri, Emanuela Esposito, Rosanna Di Paola, Akbar Ahmad, Michela Campolo, Angelo Peli, Valeria Maria Morittu, Domenico Britti, Salvatore Cuzzocrea

Erschienen in: Arthritis Research & Therapy | Ausgabe 1/2016

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
The online version of the original article can be found under doi:10.​1186/​ar4382.
The online version of the original article can be found at http://​dx.​doi.​org/​10.​1186/​ar4382.

Competing interests

Prof. Salvatore Cuzzocrea, researcher on the study team, is a co-inventor on a patent (Application number: 20150057269) with Epitech, along with academic investigators from different institutions and not studied in the above-referenced manuscript. In particular, this patent deals with compositions and methods for the modulation of amidases capable of hydrolysing N-acylethanolamines useable in the therapy of inflammatory diseases. No other authors have competing interests.
The authors would like to issue an erratum for this article [1], and would like to declare the following competing interests which we inadvertently failed to include in our original publication. The authors would like to apologise for this omission.
In addition, a detailed method for co-ultramicronization process is reported:
Co-ultramicronization process was performed in a jet-mill equipment endowed with a chamber of 300 mm in diameter which operates with “spiral technology” and was driven by compressed air at 10-12 bars. The crashing is determined by the high number of collisions that occurs among particles, as a result of the high level of kinetic – not mechanical - energy. This process was effective not only in reducing the products particle size, but also in modifying their crystalline structure. Observations by scanning electron microscopy (SEM) shows an intimate intermixing of the two components of the composite, while analysis throw differential scanning calorimetry (DSC) and X-ray diffraction (XRD) have documented the transformation in a new crystalline form different from the original two, definable with “a higher energy content form.” The composite shows the following particle size distribution: 96 % <10 μm; 80 % <5 μm; 40 % <2 μm (J Neuroinflammation 2013 10:91).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interests

Prof. Salvatore Cuzzocrea, researcher on the study team, is a co-inventor on a patent (Application number: 20150057269) with Epitech, along with academic investigators from different institutions and not studied in the above-referenced manuscript. In particular, this patent deals with compositions and methods for the modulation of amidases capable of hydrolysing N-acylethanolamines useable in the therapy of inflammatory diseases. No other authors have competing interests.
download
DOWNLOAD
print
DRUCKEN
Literatur
1.
Zurück zum Zitat Impellizzeri D, Esposito E, Di Paola R, Ahmad A, Campolo M, Peli A, et al. Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice. Arthritis Res Ther. 2013;15:R192.CrossRefPubMedPubMedCentral Impellizzeri D, Esposito E, Di Paola R, Ahmad A, Campolo M, Peli A, et al. Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice. Arthritis Res Ther. 2013;15:R192.CrossRefPubMedPubMedCentral
Metadaten
Titel
Erratum to: Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice
verfasst von
Daniela Impellizzeri
Emanuela Esposito
Rosanna Di Paola
Akbar Ahmad
Michela Campolo
Angelo Peli
Valeria Maria Morittu
Domenico Britti
Salvatore Cuzzocrea
Publikationsdatum
01.12.2016
Verlag
BioMed Central
Erschienen in
Arthritis Research & Therapy / Ausgabe 1/2016
Elektronische ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-016-0999-9

Weitere Artikel der Ausgabe 1/2016

Arthritis Research & Therapy 1/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.